[1]Chinese Rheumatology Association.Guidelines for the diagnosis an treatment of systemic sclerosis[J].Chin J Rheumatol, 2011, 15 (4) :256-259. (in Chinese) 中华医学会风湿病学分会.系统性硬化病诊断及治疗指南[J].中华风湿病学杂志, 2011, 15 (4) :256-259.
|
[2]YANG JQ, YANG G, LIU YL, et al.Surgical treatment for skin dystrophic calcinosis of the forearm and hand in patient with CREST syndrome:1 case report and literature review[J].Clin Med, 2013, 33 (6) :36-38. (in Chinese) 杨家全, 杨光, 刘玉连, 等.CREST综合征前臂及手部皮肤营养不良性钙沉着的手术治疗 (附1例报道及文献回顾) [J].临床医学, 2013, 33 (6) :36-38.
|
[3]LEI XM.Recent advances in the research of amyopathic dermatomyositisce[J].J Clin Intern Med, 2007, 24 (7) :446-448. (in Chinese) 雷小妹.无肌病性皮肌炎研究进展[J].临床内科杂志, 2007, 24 (7) :446-448.
|
[4]GU YS.The advance in the diagnosis and therapy of dermatomyositis[J].J Clin Dermatol, 2006, 35 (6) :407-409.顾有守.皮肌炎诊断和治疗进展[J].临床皮肤科杂志, 2006, 35 (6) :407-409.
|
[5]TALWALKAR JA, LINDOR KD.Primary biliary cirrhosis[J].Lancet, 2003, 362 (9377) :53-61.
|
[6]Chinese Society of Hepatology, Chinese Society of Gastroenterology, Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis) (2015) [J].J Clin Hepatol, 2015, 31 (12) :1980-1988. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会等.原发性胆汁性肝硬化 (又名原发性胆汁性胆管炎) 诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2015, 31 (12) :1980-1988.
|
[7]LIU L, LI XD, XIAO MZ, et al.Correlation analysis of autoantibodies and biochemical indicators in patients with autoimmune hepatitis typeⅠ[J/CD].Chin J Liver Dis:Electronic Version, 2016, 8 (2) :14-18.刘玲, 李晓东, 肖明中, 等.自身免疫性肝炎Ⅰ型患者自身抗体与血清生物化学指标的相关性分析[J/CD].中国肝脏病杂志:电子版, 2016, 8 (2) :14-18.
|
[8]Chinese Society of Hepatology, Chinese Society of Gastroenterology, Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of autoimmune hepatitis (2015) [J].J Clin Hepatol, 2016, 32 (1) :9-22. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :9-22.
|
[9]LINDOR KD, KOWDLEY KV, HARRISON ME.ACG Clinical Guideline:primary sclerosing cholangitis[J].Am J Gastroenterol, 2015, 110 (5) :646-659, 660.
|
[10] Chinese Society of Hepatology, Chinese Society of Gastroenterology, Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of primary sclerosing cholangitis (2015) [J].J Clin Hepatol, 2016, 32 (1) :23-31. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.原发性硬化性胆管炎诊断和治疗专家共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :23-31.
|
[11]CHAPMAN R, FEVERY J, KALLOO A, et al.Diagnosis and management of primary sclerosing cholangitis[J].Hepatology, 2010, 51 (2) :660-678.
|
[12]European Association for the Study of the Liver.Clinical Practice Guidelines:management of cholestatic liver diseases[J].J Hepatol, 2009, 51 (2) :237-267.
|
[13]HIGASHIYAMA H, YOSHIMOTO D, OKAMOTO Y, et al.Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis[J].J Clin Pathol, 2007, 60 (3) :283-289.
|
[14]JONARD P, GEUBEL A, WALLON J, et al.Primary sclerosing cholangitis and idiopathic pulmonary fibrosis:a case report[J].Acta Clin Belg, 1989, 44 (1) :24-30.
|